Zobrazeno 1 - 10
of 102
pro vyhledávání: '"Silvia Benvenuti"'
Autor:
Federica Verginelli, Alberto Pisacane, Gennaro Gambardella, Antonio D’Ambrosio, Ermes Candiello, Marco Ferrio, Mara Panero, Laura Casorzo, Silvia Benvenuti, Eliano Cascardi, Rebecca Senetta, Elena Geuna, Andrea Ballabio, Filippo Montemurro, Anna Sapino, Paolo M. Comoglio, Carla Boccaccio
Publikováno v:
Nature Communications, Vol 12, Iss 1, Pp 1-16 (2021)
Cancer of unknown primary (CUP) is a mysterious malignancy featuring metastatic dissemination in the absence of a recognizable primary tumor. By characterizing CUP cancer stem cells we show that self-sustained long-term propagation and sensitivity to
Externí odkaz:
https://doaj.org/article/4477922c33134d2989690669cbc5e8c0
Autor:
Silvia Benvenuti, Melissa Milan, Elena Geuna, Alberto Pisacane, Rebecca Senetta, Gennaro Gambardella, Giulia M Stella, Filippo Montemurro, Anna Sapino, Carla Boccaccio, Paolo M Comoglio
Publikováno v:
EMBO Molecular Medicine, Vol 12, Iss 7, Pp n/a-n/a (2020)
Abstract Cancer of unknown primary (CUP) is an obscure disease characterized by multiple metastases in the absence of a primary tumor. No consensus has been reached whether CUPs are simply generated from cancers that cannot be detected or whether the
Externí odkaz:
https://doaj.org/article/a3a098358273454aa580ffa5d68aa70d
Publikováno v:
EBioMedicine, Vol 24, Iss C, Pp 34-42 (2017)
The molecular and cellular mechanisms which drive metastatic spread are the topic of constant debate and scientific research due to the potential implications for cancer patients' prognosis. In addition to genetics and environmental factors, mechanic
Externí odkaz:
https://doaj.org/article/9a0f61a5f79249488aeb8147befe00c5
Autor:
Omid Zarei, Maryam Hamzeh-Mivehroud, Silvia Benvenuti, Fulya Ustun-Alkan, Siavoush Dastmalchi
Publikováno v:
Advanced Pharmaceutical Bulletin, Vol 7, Iss 1, Pp 141-150 (2017)
Purpose: Implication of protein-protein interactions (PPIs) in development of many diseases such as cancer makes them attractive for therapeutic intervention and rational drug design. RON (Recepteur d’Origine Nantais) tyrosine kinase receptor has g
Externí odkaz:
https://doaj.org/article/8a2a17f8822641dd925e27882a08c71e
Autor:
Vladimir Nosi, Alessandrì Luca, Melissa Milan, Maddalena Arigoni, Silvia Benvenuti, Davide Cacchiarelli, Marcella Cesana, Sara Riccardo, Lucio Di Filippo, Francesca Cordero, Marco Beccuti, Paolo M. Comoglio, Raffaele A. Calogero
Publikováno v:
International Journal of Molecular Sciences, Vol 22, Iss 8, p 4217 (2021)
Background: Disruption of alternative splicing (AS) is frequently observed in cancer and might represent an important signature for tumor progression and therapy. Exon skipping (ES) represents one of the most frequent AS events, and in non-small cell
Externí odkaz:
https://doaj.org/article/a2366495b02d45b1b1942f37ca42d51b
Autor:
Melissa Milan, Silvia Benvenuti, Alice Maria Balderacchi, Anna Rita Virzì, Alessandra Gentile, Rebecca Senetta, Paola Cassoni, Paolo Maria Comoglio, Giulia Maria Stella
Publikováno v:
ERJ Open Research, Vol 4, Iss 1 (2018)
Externí odkaz:
https://doaj.org/article/e86d313a7dda4b6f9e4611d6a1149ef4
Autor:
Giulia M. Stella, Alessandra Gentile, Alice Balderacchi, Federica Meloni, Melissa Milan, Silvia Benvenuti
Publikováno v:
Journal of Translational Medicine, Vol 15, Iss 1, Pp 1-1 (2017)
Abstract In the original version of this article [1], published on 2 September 2016, the name of author ‘Alice Balderacchi’ was wrongly displayed. In this Erratum the incorrect name and correct name are shown. The original publication of this art
Externí odkaz:
https://doaj.org/article/160e5fc4d47e4998bdd8c08ff8e59cb8
Supplementary Figure 4 from Ror1 Is a Pseudokinase That Is Crucial for Met-Driven Tumorigenesis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6d2f9657e936a93174fc270505985a72
https://doi.org/10.1158/0008-5472.22390235
https://doi.org/10.1158/0008-5472.22390235
The human kinome includes Ror1, a poorly characterized orphan receptor. Here we report the findings of an investigation of Ror1 contributions to cancer, undertaken through an integrated screening of 43 cancer cell lines where we measured protein expr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::eec11d7edf8c77d023652bab3c698c05
https://doi.org/10.1158/0008-5472.c.6502874.v1
https://doi.org/10.1158/0008-5472.c.6502874.v1
Supplementary Figure 2 from Ror1 Is a Pseudokinase That Is Crucial for Met-Driven Tumorigenesis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::84d779cbe365dc3e1dcc0abc9625c989
https://doi.org/10.1158/0008-5472.22390241
https://doi.org/10.1158/0008-5472.22390241